Biotest
BIO.F
42,00 €
Share price
0.48%
Change (1 day)
1.90%
Change (1 year)
Categories
Revenue for Biotest (BIO.F)
Revenue in 2024 (TTM): €0.70 Billion
According to Biotest
's latest financial reports the company's current revenue (TTM 
) is €0.70 Billion. In 2023 the company made a revenue of €0.68 Billion an increase over the revenue in the year 2022 that were of €0.51 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biotest from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | €0.70 B | 3.29% |
| 2023 | €0.68 B | 32.63% |
| 2022 | €0.51 B | 0.1% |
| 2021 | €0.51 B | 6.48% |
| 2020 | €0.48 B | 15.53% |
| 2019 | €0.41 B | 4.67% |
| 2018 | €0.40 B | 52.01% |
| 2017 | €0.26 B | -48.48% |
| 2016 | €0.51 B | -13.28% |
| 2015 | €0.58 B | 1.31% |
| 2014 | €0.58 B | 16.21% |
| 2013 | €0.50 B | 13.83% |
| 2012 | €0.43 B | 4.25% |
| 2011 | €0.42 B | 12.19% |
| 2010 | €0.37 B | -14.54% |
| 2009 | €0.44 B |